Immediate Impact

34 standout
Sub-graph 1 of 14

Citing Papers

AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Pancreatic cancer
2025 Standout
4 intermediate papers

Works of Yen‐Yang Chen being referenced

Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact
2019
MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients
2018

Author Peers

Author Last Decade Papers Cites
Yen‐Yang Chen 123 76 79 19 202
Vijay Trisal 159 129 74 20 287
Christine Deutschmann 134 93 51 17 224
M. Thalhammer 109 129 14 26 233
Rong Li 100 135 58 27 287
J P Bellocq 83 136 14 17 272
Wouter J.M. Derksen 159 160 14 22 260
Jean-François Delattre 70 145 38 19 263
Hyun‐Dong Chae 169 131 123 24 293
Heung-Moon Chang 165 118 81 16 276
Harika Tirumani 203 86 42 22 295

All Works

Loading papers...

Rankless by CCL
2026